Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2009
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The company provides contract professionals, contract-to-permanent placement, and direct placement services.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Revenues | $116.8 million | $152.4 million |
| Gross Profit | $37.0 million | $47.4 million |
| Gross Margin | 31.7% | 31.1% |
| Operating Income | $3.9 million | $7.7 million |
| Net Income | $1.6 million | $2.4 million |
| Diluted EPS | $0.05 | $0.07 |
| Cash from Operations | $18.2 million | $6.8 million |
| Cash & Equivalents (End of Period) | $46.5 million | $42.9 million |
| Long-Term Debt | $110.9 million | $125.9 million |
| Working Capital | $80.2 million | $91.2 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 23.4% ($35.6 million) year-over-year. Significant declines occurred in IT and Engineering (-30.3%), Healthcare (-29.2%), and Life Sciences (-22.1%) due to economic downturns and reduced client demand. The Physician segment was the only growth area, increasing 5.7%.
- Margin Expansion: Despite revenue drops, consolidated gross margin expanded by 60 basis points to 31.7%, driven by improved bill/pay spreads in Healthcare and Physician segments.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased 16.5% to $33.1 million, primarily due to reduced headcount and lower amortization expenses.
- Debt Reduction: Long-term debt decreased by $15.0 million following a principal payment made in March 2009 as a condition of a credit facility amendment.
- Cash Flow Improvement: Operating cash flow increased significantly to $18.2 million (from $6.8 million), attributed to improved days sales outstanding and lower accounts receivable balances.
Outlook, Risks, and Management Commentary
- Outlook: Management expects a challenging operating environment but notes signs of stabilizing demand in Life Sciences and IT/Engineering. The focus remains on maintaining margins and generating cash.
- Credit Facility Amendment: On March 27, 2009, the company amended its senior credit facility. The maximum leverage ratio was increased to 3.25:1.00 for 2009, and the interest coverage ratio was raised to 4.00:1.00. The amendment included a 3.0% LIBOR floor and a 150 basis point increase in the loan spread.
- Goodwill Impairment Test: Due to deteriorating economic conditions and a drop in stock price, the company performed an interim goodwill impairment test as of March 31, 2009. No impairment was identified, though management notes that further declines in stock price or forecasts could trigger impairment in the future.
- Risks: Key risks include the global credit crisis, reduced demand for staffing services, availability of qualified professionals, and the potential for goodwill impairment if market capitalization falls significantly below book value.
- Unusual Items: The company recorded a $0.6 million non-cash expense in the Physician segment related to an adjustment of the discount rate for medical malpractice liability. Additionally, $10.0 million was paid down on the term loan in April 2009 (post-period).
Investor Verification Checklist
- Debt Covenant Compliance: Verify continued compliance with the amended leverage and interest coverage ratios given the economic volatility.
- Goodwill Valuation: Monitor stock price performance and segment forecasts for potential future goodwill impairment charges.
- Segment Recovery: Assess whether the stabilizing demand in Life Sciences and IT/Engineering translates to revenue growth in subsequent quarters.
- Earn-out Obligations: Confirm the timing and payment of the $4.8 million Oxford earn-out expected in Q2 2009.
- Self-Insurance Reserves: Review the adequacy of the $10.4 million workers' compensation and medical malpractice loss reserves.